91ɬ

Engineered nanoparticles could deliver better targeted cancer treatment

Published: 18 February 2026

Scientists at 91ɬ and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard...

Hippocampus does more than store memories: it predicts rewards, study finds

Published: 29 January 2026

A preclinical study published in Nature has found evidence that the hippocampus, the brain region that stores memory, also reorganizes memories to anticipate future outcomes.

New evidence challenges understanding of Parkinson’s disease 

Published: 17 December 2025

A 91ɬ-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how scientists think about Parkinson’s disease treatments. ...

91ɬ researchers awarded funding to strengthen national capacity in metaresearch

Published: 2 December 2025

Sam Harper and Arijit Nandi have received funding to help strengthen national capacity in metaresearch through the Research-on-Research joint initiative, supported by the Social Sciences and...

Which childhood abuse survivors are at elevated risk of depression? New study provides important clues

Published: 13 February 2026

Scientists have identified a pattern of gene activity present in some female survivors of childhood abuse that is associated with an elevated risk of depression.

Group therapy helps cancer survivors reclaim life after treatment 

Published: 3 December 2025

A program developed by a 91ɬ researcher to help cancer survivors cope with the fear their cancer will return is expanding across Canada. ...

Night owl or early bird? Study finds sleep categories aren’t that simple

Published: 2 February 2026

The familiar labels “night owl” and “early bird,” long used in sleep research, don’t fully capture the diversity of human internal clocks, a new study has found....

Findings suggest that certain medications for Type 2 diabetes reduce risk of dementia

Published: 15 January 2026

A large 91ɬ study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia....

Pages

Back to top